TYMS and non-small cell lung carcinoma: Previous studies have shown that overexpression of TYMS in human non-small cell lung cancer (NSCLC) tumor cell lines reduced sensitivity to pemetrexed while downregulation of TYMS restored sensitivity of these cells to the proapoptotic effect of the drug [37].